SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-16-000496
Filing Date
2016-01-07
Accepted
2016-01-07 18:24:05
Documents
1
Period of Report
2016-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_3609.html 4  
1 PRIMARY DOCUMENT doc4_3609.xml 4 4031
  Complete submission text file 0001638599-16-000496.txt   5496
Mailing Address AUXILIUM PHARMACEUTICALS, INC. 40 VALLEY STREAM PARKWAY MALVERN PA 19355
Business Address
Mattila Jyrki (Reporting) CIK: 0001297318 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 161331104

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations